Categories AlphaGraphs, Earnings, Health Care
Infographic: Thermo Fisher Scientific (TMO) Q2 2023 Earnings Results
Thermo Fisher Scientific Inc. (NYSE: TMO) reported second quarter 2023 earnings results today.
Revenue declined 3% to $10.69 billion compared to the same period a year ago. Core organic revenue grew 2%.
Net income attributable to Thermo Fisher Scientific Inc. was $1.36 billion, or $3.51 per share, compared to $1.66 billion, or $4.22 per share, last year. Adjusted EPS was $5.15.
The company expects FY2023 revenue to be $43.4-44.0 billion and adjusted EPS to be $22.28-22.72.
Prior performance
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
